| PD-L1 expression as a predictive biomarker in cancer immunotherapy SP Patel, R Kurzrock Molecular cancer therapeutics 14 (4), 847-856, 2015 | 2152 | 2015 |
| Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers AM Goodman, S Kato, L Bazhenova, SP Patel, GM Frampton, V Miller, ... Molecular cancer therapeutics 16 (11), 2598-2608, 2017 | 2058 | 2017 |
| Microbiome analyses of blood and tissues suggest cancer diagnostic approach GD Poore, E Kopylova, Q Zhu, C Carpenter, S Fraraccio, S Wandro, ... Nature 579 (7800), 567-574, 2020 | 792 | 2020 |
| NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 19 (3), 254-266, 2021 | 784 | 2021 |
| Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology DS Ettinger, DE Wood, DL Aisner, W Akerley, JR Bauman, A Bharat, ... Journal of the National Comprehensive Cancer Network 20 (5), 497-530, 2022 | 697 | 2022 |
| NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines DS Ettinger, DE Wood, C Aggarwal, DL Aisner, W Akerley, JR Bauman, ... Journal of the National Comprehensive Cancer Network 17 (12), 1464-1472, 2019 | 667 | 2019 |
| NCCN guidelines insights: non–small cell lung cancer, version 5.2018 DS Ettinger, DL Aisner, DE Wood, W Akerley, J Bauman, JY Chang, ... Journal of the National Comprehensive Cancer Network 16 (7), 807-821, 2018 | 502 | 2018 |
| Management of immunotherapy-related toxicities, version 1.2019, NCCN clinical practice guidelines in oncology JA Thompson, BJ Schneider, J Brahmer, S Andrews, P Armand, S Bhatia, ... Journal of the National Comprehensive Cancer Network 17 (3), 255-289, 2019 | 489 | 2019 |
| PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas A Goodman, SP Patel, R Kurzrock Nature reviews Clinical oncology 14 (4), 203-220, 2017 | 415 | 2017 |
| NCCN guidelines insights: management of immunotherapy-related toxicities, version 1.2020: featured updates to the NCCN guidelines JA Thompson, BJ Schneider, J Brahmer, S Andrews, P Armand, S Bhatia, ... Journal of the National Comprehensive Cancer Network 18 (3), 230-241, 2020 | 352 | 2020 |
| ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment N Li, Y Kang, L Wang, S Huff, R Tang, H Hui, K Agrawal, GM Gonzalez, ... Proceedings of the National Academy of Sciences 117 (33), 20159-20170, 2020 | 344 | 2020 |
| Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States Nature medicine 26 (6), 861-868, 2020 | 337 | 2020 |
| A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART SWOG 1609) in patients with nonpancreatic neuroendocrine tumors SP Patel, M Othus, YK Chae, FJ Giles, DE Hansel, PP Singh, A Fontaine, ... Clinical Cancer Research 26 (10), 2290-2296, 2020 | 262 | 2020 |
| Association of patient sex with efficacy of immune checkpoint inhibitors and overall survival in advanced cancers: a systematic review and meta-analysis CJD Wallis, M Butaney, R Satkunasivam, SJ Freedland, SP Patel, ... JAMA oncology 5 (4), 529-536, 2019 | 217 | 2019 |
| Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group S Stacchiotti, A Gronchi, P Fossati, T Akiyama, C Alapetite, M Baumann, ... Annals of Oncology 28 (6), 1230-1242, 2017 | 199 | 2017 |
| Hypermutated circulating tumor DNA: correlation with response to checkpoint inhibitor–based immunotherapy Y Khagi, AM Goodman, GA Daniels, SP Patel, AG Sacco, JM Randall, ... Clinical Cancer Research 23 (19), 5729-5736, 2017 | 196 | 2017 |
| Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss JJ Kril, S Patel, AJ Harding, GM Halliday Journal of Neurology, Neurosurgery & Psychiatry 72 (6), 747-751, 2002 | 185 | 2002 |
| Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions L Narunsky-Haziza, GD Sepich-Poore, I Livyatan, O Asraf, C Martino, ... Cell 185 (20), 3789-3806. e17, 2022 | 183 | 2022 |
| Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants J Arnout Thrombosis and haemostasis 86 (07), 83-91, 2001 | 181 | 2001 |
| Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology JA Thompson, BJ Schneider, J Brahmer, A Achufusi, P Armand, ... Journal of the National Comprehensive Cancer Network 20 (4), 387-405, 2022 | 173 | 2022 |
Razelle Kurzrock, MDProfessor of Medicine, Medical College of WisconsinVerified email at mcw.edu
